The International NASH day, on June 12th, is a great initiative by Global Liver Institute (endorsed by both the European and the American associations for the study of liver, EASL and AASLD, to increase awareness around the globe about NAFLD (Nonalcoholic fatty liver disease) and NASH (Nonalcoholic Steatohepatitis) and the actions people can take to address these diseases. This year it is taking place as a virtual event and social media campaign.
Link to The International NASH day and its activities
Antaros Medical and NASH
Non-alcoholic fatty liver disease is affecting 25-30% of the adult population worldwide. The progressive form, non-alcoholic steatohepatitis (NASH), comes with an increased risk of advanced fibrosis, cirrhosis and liver-related mortality. It is crucial to understand this progress and severity of the disease for both clinical management and clinical research. The use of Magnetic Resonance Imaging (MRI) biomarkers are increasing and are important non-invasive alternatives for both clinical research and clinical management of patients.
Read more about Antaros Medical and fatty liver disease including NASH